HCPro, JustCoding Outpatient - 2022 Issue 8 (February)
Tackle 2022 ICD-10-CM coding for thrombotic microangiopathy
February 21st, 2022
Subscribe or sign in to view the full article.
Article Overview
This article explains thrombotic microangiopathy (TMA) from a clinical and coding perspective, with emphasis on the 2022 ICD-10-CM changes. It covers the condition’s general presentation, diagnostic context, transplant-associated coding considerations, related organ dysfunction reporting, and how COVID-19 and post-COVID-19 conditions may intersect with TMA. It is useful for coders, auditors, and clinical documentation specialists who work with hematology, nephrology, transplant, and infectious disease records.
Why This Topic Matters
TMA can be associated with multiple underlying conditions and organ complications, making accurate diagnosis coding more complex. The 2022 ICD-10-CM updates add new reporting options and related guidance that affect code selection in transplant, post-COVID-19, and multisystem cases.
Article Sections
-
Thrombotic microangiopathy overview
Introduces TMA as a rare syndrome and summarizes broad clinical features, common associations, and general pathophysiology.
-
Diagnostic testing
Reviews the types of testing used to support diagnosis and the general approach to identifying an underlying cause.
-
ICD-10-CM coding
Summarizes the 2022 ICD-10-CM updates for TMA and the related guidance that accompanies them.
-
TMA and COVID-19
Discusses the article’s overview of the relationship between TMA, COVID-19, and post-COVID-19 conditions.
-
Acquired TMA
Covers the article’s discussion of acquired forms of TMA and related documentation considerations.
-
Treatment for TMA
Provides a broad overview of treatment approaches and how management may vary with the underlying cause.
What You Will Learn
- How TMA is presented clinically and why it can be difficult to classify
- What kinds of diagnostic evaluation are discussed in relation to TMA
- Which 2022 ICD-10-CM TMA coding updates are highlighted
- How transplant-related and organ-dysfunction reporting is addressed
- How COVID-19 and post-COVID-19 conditions are discussed alongside TMA
- What general treatment themes are mentioned for different TMA scenarios
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation specialists
- Hematology billing staff
- Nephrology billing staff
- Transplant coding professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.



Quick, Current, Complete - www.findacode.com